tiprankstipranks
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market
Holding AU:AGN?
Track your performance easily

Argenica Therapeutics Ltd (AGN) Income Statement

9 Followers

Argenica Therapeutics Ltd Income Statement

Last quarter (Q4 2022), Argenica Therapeutics Ltd's total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Argenica Therapeutics Ltd's net income was AU$―. See Argenica Therapeutics Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
-AU$ 4.35MAU$ 1.33M
Operating Income
-AU$ -4.35MAU$ -1.33M
Net Non Operating Interest Income Expense
-AU$ 1.68KAU$ 182.00
Other Income Expense
-AU$ 259.10KAU$ 296.07K
Pretax Income
-AU$ -4.09MAU$ -1.03M
Tax Provision
-AU$ 0.00AU$ 54.00
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
-AU$ -4.09MAU$ -1.03M
Basic EPS
-AU$ -0.06AU$ -0.03
Diluted EPS
-AU$ -0.06AU$ -0.03
Basic Average Shares
-AU$ 73.93MAU$ 35.40M
Diluted Average Shares
-AU$ 73.93MAU$ 35.40M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
---
Net Income From Continuing And Discontinued Operation
-AU$ -4.09MAU$ -1.03M
Normalized Income
-AU$ -4.09MAU$ -1.03M
Interest Expense
-AU$ 822.00AU$ 20.00
EBIT
-AU$ -4.09MAU$ -1.03M
EBITDA
-AU$ -4.09MAU$ -1.03M
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis